注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Vivos Therapeutics Inc是一家医疗技术公司。该公司专注于为患有牙颌面异常的患者,患有轻度至中度阻塞性睡眠呼吸暂停(OSA)和成人打鼾的患者开发商业化诊断和治疗方式。该公司将其OSA治疗方案称为Vivos方法。Vivos方法是一种非侵入性、非手术、非药物、多学科的治疗方式,用于治疗牙颌畸形和/或轻度至中度OSA和打鼾。该公司的计划是培训牙医并为他们提供与他们为患者订购和使用Vivos系统相关的其他增值服务,称为Vivos综合实践计划。该公司在Vivos系统中使用的主要产品是下颌骨重新定位夜间矫治器(mRNA),这是一种专门设计的定制口腔矫治器。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Ralph E. Green | 84 | 2020 | Independent Director |
Jon Caulfield | - | 2021 | Member of Medical & Clinical Advisory Board |
Anja B. Krammer | 56 | 2020 | Independent Director |
Tammarie Heit | - | 2021 | Member of Medical & Clinical Advisory Board |
R. Kirk Huntsman | 66 | 2016 | Co-Founder, Chairman of the Board & CEO |
Leonard Jay Sokolow | 67 | 2020 | Independent Director |
Michael Gelb | - | 2021 | Member of Medical & Clinical Advisory Board |
Manisha Witmans | - | 2021 | Member of Medical & Clinical Advisory Board |
Edward J. Zuckerberg | - | 2021 | Member of Medical & Clinical Advisory Board |
Mark F. Lindsay | 60 | 2020 | Independent Director |
Matthew Thompson | 62 | 2020 | Independent Director |
Seth Heckman | - | - | Member of Medical & Clinical Advisory Board |
Lindsay Williams | - | - | Member of Medical & Clinical Advisory Board |
Clete A. Kushida | - | 2021 | Co-Chair of Medical & Clinical Advisory Board |
Cecilia Wu | - | - | Co-Chair of Medical & Clinical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核